Madrigal Pharmaceuticals, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersConshohocken, PA
US patents25
SAM.gov UEIKA81N6BWY8L9
CAGE code9TCT2
Incorporated inDE
LEI549300CHIMT2EUSNJB60
- metabolic dysfunction-associated steatohepatitis
- MASH
- liver disease
- first U.S
- Food
- Drug Administration
- approved treatment
- medical professionals
Named on the company’s own website, read SEP 9, 2026
Open positions
Openings read from Madrigal Pharmaceuticals, INC’s own job board on Workday, last checked NOV 10, 2026. FactoryRegistry does not host applications — each title opens the posting where the company published it.
- Area Business Manager, Chicago NorthIL - Illinois - Field · posted NOV 10, 2026
- Senior Director, Clinical OperationsPA - Conshohocken - Office · posted NOV 10, 2026
- Director, Agentic AI and AutomationPA - Conshohocken - Office · posted NOV 10, 2026
- Regional Sales Director- Pacific NorthwestWA - Washington - Field · posted NOV 7, 2026
- Area Business Manager, Orange County SouthCA - California - Field · posted NOV 7, 2026
- Senior Treasury AnalystMA - Waltham - Office · posted NOV 6, 2026
- Senior Manager – AccountingPA - Conshohocken - Office · posted NOV 6, 2026
- Director, Drug Product Small Molecule SMEPA - Conshohocken - Office · posted NOV 6, 2026
- Director, Drug Product siRNA SMEPA - Conshohocken - Office · posted NOV 6, 2026
- Key Account Director - HeartlandKansas City, MO · posted NOV 4, 2026
49 more on the company’s board
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
25 US patents granted 2012–2025, 9 of them in the five years to SEP 2025.
Pharmaceuticals 18Organic fine chemistry 6Measurement 1
- Methods for treating a fatty liver diseaseUS 12,377,104 · granted AUG 5, 2025
- Method of synthesizing thyroid hormone analogs and polymorphs thereofUS 11,986,481 · granted MAY 21, 2024
- Methods of treating liver disorders or lipid disorders with a THR-beta agonistUS 11,806,353 · granted NOV 7, 2023
- Methods of synthesizing thyroid hormone analogs and polymorphs thereofUS 11,564,926 · granted JAN 31, 2023
- Combination therapies comprising targeted therapeuticsUS 11,491,145 · granted NOV 8, 2022
Newest 5 shown · Granted to Madrigal Pharmaceuticals, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Madrigal Pharmaceuticals, INC | Conshohocken | PA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


